Tony Goodman - 27 Jun 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ Tony Goodman
Issuer symbol
ADIL
Transactions as of
27 Jun 2022
Net transactions value
$0
Form type
4
Filing time
28 Jun 2022, 18:02:41 UTC
Previous filing
25 Feb 2022
Next filing
25 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option Award $0 +25,000 $0.000000 25,000 27 Jun 2022 Common Stock 25,000 $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months.